Richard E. Frye

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Richard Eugene Frye
Fields Child psychiatry
Institutions University of Arkansas for Medical Sciences, University of Texas Health Science Center at Houston
Alma mater Long Island University C. W. Post Campus, Drexel University
Thesis An exploration of methods for evaluating the usefulness of new and existing aerodynamic equations in detecting nasal airway disease (1992)
Known for Researching possible environmental causes of autism, as well as the potential use of supplements to treat it.

Richard Eugene Frye is an American autism researcher and associate professor at the University of Arkansas for Medical Sciences's department of pediatrics,[1] as well as the Director of the Autism Multispecialty Clinic at Arkansas Children’s Hospital.[2] Frye was formerly a faculty member at the University of Texas Health Science Center at Houston's division of child and adolescent neurology.[3]

Education[edit]

Frye received his bachelor's degree from Long Island University C. W. Post Campus in 1986 in psychobiology. Five years later, he obtained his M.S. from Drexel University in biomedical science/biostatistics. Frye went on to obtain his PhD and MD degrees both in 1998, and both from Georgetown University. From 1998 to 2000 Frye completed a residency in pediatrics at Jackson Memorial Hospital, before traveling to Children's Hospital Boston (CHB) to complete another residency, this time in pediatric neurology. After completing his residencies, he completed a research fellowship in behavioral neurology and learning disabilities, also at CHB, from 2003 to 2005. From 2004 to 2005 Frye completed another research fellowship, this time at Boston University in psychology.

Research[edit]

Frye's most cited paper is one published in 1990, which studied the effects of cigarette smoking on the sense of smell.[4] In fact, much of Frye's early research focused on olfaction.[5][6]

Frye's more recent research focuses on the potential environmental causes of autism, as well as physiological abnormalities that have been observed in autistic individuals. Specifically, he and his co-authors, who include Dan Rossignol, have concluded that it is possible that autistic individuals suffer from immune dysregulation and oxidative stress, as well as that mitochondrial dysfunction is more common in such individuals than in the general population.[7][8] In addition, Frye's research has concluded that autism may be caused by exposure to toxicants.[9] Frye has also published research on the use of dietary supplements as autism treatments, including melatonin[10] and tetrahydrobiopterin,[11] and recently coauthored a review regarding treatments for children suffering from both autism and seizures, which concluded that "limited evidence is available on the effectiveness of treatments for seizures in children with autism." However, Frye also said that this paper "...demonstrates that certain treatments could be beneficial for treating both autism symptoms and seizures at the same time."[12][13] Another of Frye's studies concluded that many autistic children have abnormal levels of gut bacteria, and that these children exhibit abnormal energy metabolism as a result.[14][15] Some have speculated that the results of this research "could create blood tests for early screening of the condition [i.e. autism]."[16]

Selected publications[edit]

References[edit]

  1. ^ "Richard E. Frye". University of Arkansas for Medical Sciences website. Retrieved 12 October 2013. 
  2. ^ Richard Frye MD PhD
  3. ^ "Richard E. Frye". University of Texas Health Science Center at Houston website. Retrieved 12 October 2013. 
  4. ^ Frye, R. E. (1990). "Dose-Related Effects of Cigarette Smoking on Olfactory Function". JAMA: the Journal of the American Medical Association 263 (9): 1233–1236. doi:10.1001/jama.1990.03440090067028.  edit
  5. ^ Doty, R. L.; Deems, D. A.; Frye, R. E.; Pelberg, R.; Shapiro, A. (1988). "Olfactory Sensitivity, Nasal Resistance, and Autonomic Function in Patients with Multiple Chemical Sensitivities". Archives of Otolaryngology - Head and Neck Surgery 114 (12): 1422–1427. doi:10.1001/archotol.1988.01860240072027. PMID 2461210.  edit
  6. ^ Doty, R. L.; Frye, R. E.; Agrawal, U. (1989). "Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test". Perception & Psychophysics 45 (5): 381. doi:10.3758/BF03210709.  edit
  7. ^ Rossignol, D. A.; Frye, R. E. (2011). "Mitochondrial dysfunction in autism spectrum disorders: A systematic review and meta-analysis". Molecular Psychiatry 17 (3): 290–314. doi:10.1038/mp.2010.136. PMC 3285768. PMID 21263444.  edit
  8. ^ Brooks, Megan (31 January 2011). "Mitochondrial Dysfunction Linked to Autism". Medscape. Retrieved 6 November 2013. 
  9. ^ Rossignol, D. A.; Frye, R. E. (2011). "A review of research trends in physiological abnormalities in autism spectrum disorders: Immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures". Molecular Psychiatry 17 (4): 389–401. doi:10.1038/mp.2011.165. PMC 3317062. PMID 22143005.  edit
  10. ^ Rossignol, D. A.; Frye, R. E. (2011). "Melatonin in autism spectrum disorders: A systematic review and meta-analysis". Developmental Medicine & Child Neurology 53 (9): 783. doi:10.1111/j.1469-8749.2011.03980.x.  edit
  11. ^ Frye, R. E.; Huffman, L. C.; Elliott, G. R. (2010). "Tetrahydrobiopterin as a novel therapeutic intervention for autism". Neurotherapeutics 7 (3): 241–249. doi:10.1016/j.nurt.2010.05.004. PMC 2908599. PMID 20643376.  edit
  12. ^ "New Recommendations on Treatments for Seizures in Autism". PR Newswire. 25 September 2013. Retrieved 12 October 2013. 
  13. ^ Frye, Richard E.; Rossignol, Dan A. (September 2013). "A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel". Frontiers in Public Health 1 (31). 
  14. ^ Frye, R. E.; Melnyk, S.; MacFabe, D. F. (2013). "Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder". Translational Psychiatry 3 (1): e220–. doi:10.1038/tp.2012.143. PMC 3566723. PMID 23340503.  edit
  15. ^ Staff (29 January 2013). "Study Reveals Link between Gut Bacteria and Autism". Scitech Daily. Retrieved 13 October 2013. 
  16. ^ "Potential Blood Test Found To Detect Autism". Medical News Today. 30 January 2013. Retrieved 13 October 2013. 

External links[edit]